The Effect of Dapagliflozin on Patients With Cardiomyopathy

NCT07076615 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Acute Decompensated Heart Failure (ADHF)

Interventions

DRUG: Dapagliflozin (DAPA)
DRUG: Diuretic

Sponsor

May Mohamed Abdalla

Collaborators

[object Object]